Delivery Order SPE2DR25D2104-SPE2DR26F3NFE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Micardis HCT 80-25 mg tablet unit dose packages (30-count) with a ceiling value of $2,217.60. This is a firm fixed-price delivery order with an ultimate completion date of October 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Micardis HCT 40-12.5 mg tablets in unit dose packaging (30 count) with a contract value of $4,957.67 and an ultimate completion date of October 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, placed under a competitive award process. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Micardis HCT 40-12.5 mg tablet unit dose packages (30 count). This competitive award, valued at $4,145.28 with firm fixed pricing, is scheduled for completion by September 2, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract contains no set-aside designation and represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Micardis HCT 80-25 mg tablets in unit dose packaging (30-count). This competitively awarded, firm fixed price delivery order carries a ceiling value of $3,758.67 and is scheduled for completion by September 3, 2025. The contract represents performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with no set-aside designation applied. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Micardis HCT 40-12.5 mg tablets (unit dose, 30 count) with a contract value of $3,124.61. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Micardis HCT 80-12.5 mg tablets in unit dose packaging (30-count). This competitively awarded, non-set-aside contract carries a ceiling value of $1,446.12 and has a firm fixed price structure, with an ultimate completion date of September 5, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Micardis HCT 40-12.5 mg tablets in unit dose packaging (30-count) valued at $3,135.92. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award supporting the federal government's pharmaceutical supply requirements. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a $1,243.66 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Micardis HCT 40-12.5 mg tablets (30 unit dose tablets). This competitively awarded, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and delivered from the contractor's facility in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Micardis HCT 80-25 mg tablets (30-count unit dose packaging) with a ceiling value of $2,783.91. This firm fixed-price delivery order is scheduled for completion by July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating open competitive procurement. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Micardis HCT 80-12.5 mg tablets in unit dose packaging (30-count) with a ceiling value of $2,508.25. This competitive, non-set-aside award utilizes firm fixed price pricing and carries an ultimate completion date of September 4, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3NFEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Micardis HCT 80-25 mg tablets (30-count unit dose packaging) with a contract value of $2,342.42. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 5, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support platform enabling the delivery of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs and other federal health systems worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to meet federal procurement requirements through competitive awards across diverse therapeutic categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/4/25 |